Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000597182 | SCV000705423 | uncertain significance | not provided | 2017-01-26 | criteria provided, single submitter | clinical testing | |
Pars Genome Lab | RCV001526429 | SCV001736815 | uncertain significance | Severe combined immunodeficiency due to DCLRE1C deficiency | 2021-05-18 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001526429 | SCV003446498 | uncertain significance | Severe combined immunodeficiency due to DCLRE1C deficiency | 2023-12-06 | criteria provided, single submitter | clinical testing | This sequence change replaces arginine, which is basic and polar, with glycine, which is neutral and non-polar, at codon 430 of the DCLRE1C protein (p.Arg430Gly). This variant is present in population databases (no rsID available, gnomAD 0.007%). This variant has not been reported in the literature in individuals affected with DCLRE1C-related conditions. ClinVar contains an entry for this variant (Variation ID: 499762). Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Not Available"; PolyPhen-2: "Benign"; Align-GVGD: "Not Available". The glycine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |